{"schema_version":"secwatch.filing_event.v1","accession":"0001356576-24-000060","form_type":"8-K","ticker":"SUPN","cik":"0001356576","company_name":"SUPERNUS PHARMACEUTICALS, INC.","filed_at":"2024-10-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.247317+00:00","generated_at":"2026-05-30T12:17:20.205319+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"medium","headline":"Supernus sets Q3 2024 earnings call for November 4 after market close","bullets":["Earnings release scheduled for Monday, November 4, 2024, after market close.","President/CEO Jack Khattar and CFO Tim Dec to host conference call at 4:30 p.m. ET.","Webcast replay available for 60 days on investor relations website."],"urls":{"canonical":"https://secwatch.observer/filing/0001356576-24-000060","json":"https://secwatch.observer/filing/0001356576-24-000060.json","markdown":"https://secwatch.observer/filing/0001356576-24-000060.md","text":"https://secwatch.observer/filing/0001356576-24-000060.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1356576/000135657624000060/0001356576-24-000060-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1356576/000135657624000060/supn-20241021.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T12:17:20.205319+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}